Selected research
Industry Growth & Trends
Global Tenapanor Industry Growth and Trends Forecast to 2032
Market perspective
The global Tenapanor market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Tenapanor is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Tenapanor is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Tenapanor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Tenapanor include Kyowa Kirin, Fosun Pharma and Ardelyx, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Tenapanor market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Tenapanor market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Tenapanor market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Tenapanor.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Tenapanor market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Tenapanor Market by Company
Kyowa Kirin
Fosun Pharma
Ardelyx
Tenapanor Segment by Type
10mg per Tablet
20mg per Tablet
30mg per Tablet
50mg per Tablet
Tenapanor Segment by Application
Irritable Bowel Syndrome with Constipation
Hyperphosphatemia
Other
Tenapanor Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tenapanor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tenapanor and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tenapanor.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tenapanor manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Tenapanor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 10mg per Tablet
- 20mg per Tablet
- 30mg per Tablet
- 50mg per Tablet
Applications
- Irritable Bowel Syndrome with Constipation
- Hyperphosphatemia
- Other
Companies covered
- Kyowa Kirin
- Fosun Pharma
- Ardelyx
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Tenapanor Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Tenapanor Sales Estimates and Forecasts (2021-2032)
- 1.3 Tenapanor Market by Type
- 1.3.1 10mg per Tablet
- 1.3.2 20mg per Tablet
- 1.3.3 30mg per Tablet
- 1.3.4 50mg per Tablet
- 1.4 Global Tenapanor Market Size by Type
- 1.4.1 Global Tenapanor Market Size Overview by Type (2021-2032)
- 1.4.2 Global Tenapanor Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Tenapanor Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Tenapanor Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Tenapanor Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Tenapanor Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Tenapanor Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Tenapanor Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Tenapanor Industry Trends
- 2.2 Tenapanor Industry Drivers
- 2.3 Tenapanor Industry Opportunities and Challenges
- 2.4 Tenapanor Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Tenapanor Revenue (2021-2026)
- 3.2 Global Top Players by Tenapanor Sales (2021-2026)
- 3.3 Global Top Players by Tenapanor Price (2021-2026)
- 3.4 Global Tenapanor Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Tenapanor Major Company Production Sites & Headquarters
- 3.6 Global Tenapanor Company, Product Type & Application
- 3.7 Global Tenapanor Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Tenapanor Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Tenapanor Players Market Share by Revenue in 2025
- 3.8.3 2025 Tenapanor Tier 1, Tier 2, and Tier 3
4 Tenapanor Regional Status and Outlook
- 4.1 Global Tenapanor Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Tenapanor Historic Market Size by Region
- 4.2.1 Global Tenapanor Sales in Volume by Region (2021-2026)
- 4.2.2 Global Tenapanor Sales in Value by Region (2021-2026)
- 4.2.3 Global Tenapanor Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Tenapanor Forecasted Market Size by Region
- 4.3.1 Global Tenapanor Sales in Volume by Region (2027-2032)
- 4.3.2 Global Tenapanor Sales in Value by Region (2027-2032)
- 4.3.3 Global Tenapanor Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Tenapanor by Application
- 5.1 Tenapanor Market by Application
- 5.1.1 Irritable Bowel Syndrome with Constipation
- 5.1.2 Hyperphosphatemia
- 5.1.3 Other
- 5.2 Global Tenapanor Market Size by Application
- 5.2.1 Global Tenapanor Market Size Overview by Application (2021-2032)
- 5.2.2 Global Tenapanor Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Tenapanor Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Tenapanor Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Tenapanor Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Tenapanor Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Tenapanor Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Tenapanor Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Kyowa Kirin
- 6.1.1 Kyowa Kirin Company Information
- 6.1.2 Kyowa Kirin Business Overview
- 6.1.3 Kyowa Kirin Tenapanor Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Kyowa Kirin Tenapanor Product Portfolio
- 6.1.5 Kyowa Kirin Recent Developments
- 6.2 Fosun Pharma
- 6.2.1 Fosun Pharma Company Information
- 6.2.2 Fosun Pharma Business Overview
- 6.2.3 Fosun Pharma Tenapanor Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Fosun Pharma Tenapanor Product Portfolio
- 6.2.5 Fosun Pharma Recent Developments
- 6.3 Ardelyx
- 6.3.1 Ardelyx Company Information
- 6.3.2 Ardelyx Business Overview
- 6.3.3 Ardelyx Tenapanor Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Ardelyx Tenapanor Product Portfolio
- 6.3.5 Ardelyx Recent Developments
7 North America by Country
- 7.1 North America Tenapanor Sales by Country
- 7.1.1 North America Tenapanor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Tenapanor Sales by Country (2021-2026)
- 7.1.3 North America Tenapanor Sales Forecast by Country (2027-2032)
- 7.2 North America Tenapanor Market Size by Country
- 7.2.1 North America Tenapanor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Tenapanor Market Size by Country (2021-2026)
- 7.2.3 North America Tenapanor Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Tenapanor Sales by Country
- 8.1.1 Europe Tenapanor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Tenapanor Sales by Country (2021-2026)
- 8.1.3 Europe Tenapanor Sales Forecast by Country (2027-2032)
- 8.2 Europe Tenapanor Market Size by Country
- 8.2.1 Europe Tenapanor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Tenapanor Market Size by Country (2021-2026)
- 8.2.3 Europe Tenapanor Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Tenapanor Sales by Country
- 9.1.1 Asia-Pacific Tenapanor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Tenapanor Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Tenapanor Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Tenapanor Market Size by Country
- 9.2.1 Asia-Pacific Tenapanor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Tenapanor Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Tenapanor Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Tenapanor Sales by Country
- 10.1.1 South America Tenapanor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Tenapanor Sales by Country (2021-2026)
- 10.1.3 South America Tenapanor Sales Forecast by Country (2027-2032)
- 10.2 South America Tenapanor Market Size by Country
- 10.2.1 South America Tenapanor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Tenapanor Market Size by Country (2021-2026)
- 10.2.3 South America Tenapanor Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Tenapanor Sales by Country
- 11.1.1 Middle East and Africa Tenapanor Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Tenapanor Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Tenapanor Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Tenapanor Market Size by Country
- 11.2.1 Middle East and Africa Tenapanor Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Tenapanor Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Tenapanor Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Tenapanor Value Chain Analysis
- 12.1.1 Tenapanor Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Tenapanor Production Mode & Process
- 12.2 Tenapanor Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Tenapanor Distributors
- 12.2.3 Tenapanor Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst